Local Anesthesia Final Exam Questions and Answers
Question 1
Which root of the maxillary molar is not consistently innervated by the PSA injection?
A. Distobuccal root of the maxillary first molar
B. Mesiobuccal root of the maxillary first molar
C. Mesiobuccal root of the third molar
D. Distobuccal root of the third molar
Correct Answer
B. Mesiobuccal root of the maxillary first molar
Question 1: Local anesthetics prevent nerve impulse propagation by blocking which
cellular mechanism?
A. Inhibition of sodium-potassium ATPase pumps
B. Blockade of voltage-gated sodium channels
C. Inhibition of calcium influx at presynaptic terminals
D. Enhancement of potassium efflux during repolarization
CORRECT ANSWER: B. Blockade of voltage-gated sodium channels
Rationale: Local anesthetics bind to specific receptor sites within voltage-gated
sodium channels, preventing sodium influx and inhibiting depolarization. This halts
action potential propagation along the nerve fiber. Sodium-potassium pumps (A)
maintain resting potential but are not blocked by local anesthetics. Calcium influx
(C) relates to neurotransmitter release, not impulse conduction. Potassium efflux (D)
occurs during repolarization and is not the primary target.
Question 2: Which local anesthetic is classified as an ester and metabolized
primarily by plasma pseudocholinesterase?
A. Lidocaine
B. Articaine
C. Procaine
D. Bupivacaine
CORRECT ANSWER: C. Procaine
Rationale: Procaine is a classic ester-type local anesthetic hydrolyzed in plasma by
pseudocholinesterase. Lidocaine (A), bupivacaine (D), and mepivacaine are amides
Page 1 of 195
,metabolized in the liver. Articaine (B) is an amide but uniquely contains an ester
linkage allowing partial plasma metabolism.
Question 3: A patient requires profound anesthesia for a mandibular molar
extraction. Which property of a local anesthetic MOST influences its potency?
A. pKa value
B. Lipid solubility
C. Protein binding
D. Molecular weight
CORRECT ANSWER: B. Lipid solubility
Rationale: Lipid solubility determines how readily the anesthetic penetrates the
nerve membrane. Higher lipid solubility correlates with greater potency (e.g.,
bupivacaine > lidocaine > procaine). pKa (A) influences onset time. Protein binding
(C) influences duration of action. Molecular weight (D) has minimal clinical impact
on potency.
Question 4: A local anesthetic with a pKa of 8.0 is administered. Given physiologic
pH of 7.4, which statement BEST describes its ionization state?
A. 100% ionized (RNH+) form
B. Predominantly non-ionized (RN) form for rapid onset
C. Approximately 20% non-ionized, 80% ionized
D. 50% non-ionized, 50% ionized
CORRECT ANSWER: C. Approximately 20% non-ionized, 80% ionized
Rationale: Using the Henderson-Hasselbalch equation, when pKa is 8.0 and pH is
7.4, the ratio favors the ionized form. Only the non-ionized form crosses the nerve
membrane, but the ionized form binds to the sodium channel receptor. The 20%
non-ionized fraction allows adequate diffusion, while the 80% ionized fraction
provides receptor binding. This balance explains onset and efficacy.
Question 5: Which vasoconstrictor is MOST commonly added to local anesthetics to
prolong duration and reduce systemic toxicity?
A. Phenylephrine
B. Norepinephrine
Page 2 of 195
,C. Epinephrine
D. Levonordefrin
CORRECT ANSWER: C. Epinephrine
Rationale: Epinephrine is the most widely used vasoconstrictor in dentistry. It
causes localized vasoconstriction, slowing anesthetic absorption, prolonging
duration, reducing peak plasma levels, and minimizing bleeding. Levonordefrin (D)
is less potent and used in specific formulations. Phenylephrine (A) and
norepinephrine (B) are rarely used in dental cartridges due to potency and
cardiovascular effects.
Question 6: A medically complex patient with uncontrolled hypertension (BP
170/100 mmHg) requires local anesthesia. What is the MAXIMUM recommended
dose of epinephrine per appointment?
A. 0.2 mg (2 cartridges of 1:100,000)
B. 0.04 mg (2 cartridges of 1:100,000)
C. 0.036 mg (2 cartridges of 1:50,000)
D. 0.18 mg (9 cartridges of 1:100,000)
CORRECT ANSWER: B. 0.04 mg (2 cartridges of 1:100,000)
Rationale: The American Heart Association and ADA recommend limiting
epinephrine to 0.04 mg (approximately 2 cartridges of 1:100,000) for patients with
significant cardiovascular disease, including uncontrolled hypertension. Standard
healthy patient limit is 0.2 mg. Options C and D exceed safe cardiovascular
thresholds.
Question 7: Which clinical sign is the EARLIEST indicator of local anesthetic systemic
toxicity (LAST)?
A. Tonic-clonic seizures
B. Cardiovascular collapse
C. Perioral numbness and tinnitus
D. Respiratory arrest
CORRECT ANSWER: C. Perioral numbness and tinnitus
Page 3 of 195
, Rationale: Central nervous system excitation occurs first due to lower seizure
threshold. Early signs include metallic taste, tinnitus, perioral numbness, dizziness,
and restlessness. Seizures (A) and respiratory arrest (D) are progressive CNS
depressant phases. Cardiovascular collapse (B) occurs later due to myocardial
depression.
Question 8: A patient experiences syncope during local anesthetic administration.
Which mechanism is PRIMARILY responsible?
A. Anaphylactic reaction to preservatives
B. Epinephrine-induced tachycardia
C. Vasovagal response causing cerebral hypoperfusion
D. Intravascular injection of anesthetic
CORRECT ANSWER: C. Vasovagal response causing cerebral hypoperfusion
Rationale: Syncope (fainting) is the most common dental emergency, typically
triggered by anxiety, pain, or prolonged standing, leading to vagal-mediated
vasodilation and bradycardia. This reduces cerebral perfusion. Anaphylaxis (A)
presents with bronchospasm and urticaria. Epinephrine (B) causes tachycardia, not
syncope. Intravascular injection (D) causes toxicity, not simple syncope.
Question 9: Which local anesthetic is associated with methemoglobinemia,
particularly in pediatric patients?
A. Lidocaine
B. Articaine
C. Prilocaine
D. Mepivacaine
CORRECT ANSWER: C. Prilocaine
Rationale: Prilocaine metabolizes to o-toluidine, which oxidizes hemoglobin to
methemoglobin, reducing oxygen-carrying capacity. Risk increases with doses >600
mg and in infants <6 months or patients with G6PD deficiency. Methylene blue is
the antidote. Lidocaine (A), articaine (B), and mepivacaine (D) do not carry this risk.
Question 10: A patient reports a "swollen lip" lasting 5 hours after mandibular
block. Which complication is MOST likely?
A. Allergic reaction
Page 4 of 195
Question 1
Which root of the maxillary molar is not consistently innervated by the PSA injection?
A. Distobuccal root of the maxillary first molar
B. Mesiobuccal root of the maxillary first molar
C. Mesiobuccal root of the third molar
D. Distobuccal root of the third molar
Correct Answer
B. Mesiobuccal root of the maxillary first molar
Question 1: Local anesthetics prevent nerve impulse propagation by blocking which
cellular mechanism?
A. Inhibition of sodium-potassium ATPase pumps
B. Blockade of voltage-gated sodium channels
C. Inhibition of calcium influx at presynaptic terminals
D. Enhancement of potassium efflux during repolarization
CORRECT ANSWER: B. Blockade of voltage-gated sodium channels
Rationale: Local anesthetics bind to specific receptor sites within voltage-gated
sodium channels, preventing sodium influx and inhibiting depolarization. This halts
action potential propagation along the nerve fiber. Sodium-potassium pumps (A)
maintain resting potential but are not blocked by local anesthetics. Calcium influx
(C) relates to neurotransmitter release, not impulse conduction. Potassium efflux (D)
occurs during repolarization and is not the primary target.
Question 2: Which local anesthetic is classified as an ester and metabolized
primarily by plasma pseudocholinesterase?
A. Lidocaine
B. Articaine
C. Procaine
D. Bupivacaine
CORRECT ANSWER: C. Procaine
Rationale: Procaine is a classic ester-type local anesthetic hydrolyzed in plasma by
pseudocholinesterase. Lidocaine (A), bupivacaine (D), and mepivacaine are amides
Page 1 of 195
,metabolized in the liver. Articaine (B) is an amide but uniquely contains an ester
linkage allowing partial plasma metabolism.
Question 3: A patient requires profound anesthesia for a mandibular molar
extraction. Which property of a local anesthetic MOST influences its potency?
A. pKa value
B. Lipid solubility
C. Protein binding
D. Molecular weight
CORRECT ANSWER: B. Lipid solubility
Rationale: Lipid solubility determines how readily the anesthetic penetrates the
nerve membrane. Higher lipid solubility correlates with greater potency (e.g.,
bupivacaine > lidocaine > procaine). pKa (A) influences onset time. Protein binding
(C) influences duration of action. Molecular weight (D) has minimal clinical impact
on potency.
Question 4: A local anesthetic with a pKa of 8.0 is administered. Given physiologic
pH of 7.4, which statement BEST describes its ionization state?
A. 100% ionized (RNH+) form
B. Predominantly non-ionized (RN) form for rapid onset
C. Approximately 20% non-ionized, 80% ionized
D. 50% non-ionized, 50% ionized
CORRECT ANSWER: C. Approximately 20% non-ionized, 80% ionized
Rationale: Using the Henderson-Hasselbalch equation, when pKa is 8.0 and pH is
7.4, the ratio favors the ionized form. Only the non-ionized form crosses the nerve
membrane, but the ionized form binds to the sodium channel receptor. The 20%
non-ionized fraction allows adequate diffusion, while the 80% ionized fraction
provides receptor binding. This balance explains onset and efficacy.
Question 5: Which vasoconstrictor is MOST commonly added to local anesthetics to
prolong duration and reduce systemic toxicity?
A. Phenylephrine
B. Norepinephrine
Page 2 of 195
,C. Epinephrine
D. Levonordefrin
CORRECT ANSWER: C. Epinephrine
Rationale: Epinephrine is the most widely used vasoconstrictor in dentistry. It
causes localized vasoconstriction, slowing anesthetic absorption, prolonging
duration, reducing peak plasma levels, and minimizing bleeding. Levonordefrin (D)
is less potent and used in specific formulations. Phenylephrine (A) and
norepinephrine (B) are rarely used in dental cartridges due to potency and
cardiovascular effects.
Question 6: A medically complex patient with uncontrolled hypertension (BP
170/100 mmHg) requires local anesthesia. What is the MAXIMUM recommended
dose of epinephrine per appointment?
A. 0.2 mg (2 cartridges of 1:100,000)
B. 0.04 mg (2 cartridges of 1:100,000)
C. 0.036 mg (2 cartridges of 1:50,000)
D. 0.18 mg (9 cartridges of 1:100,000)
CORRECT ANSWER: B. 0.04 mg (2 cartridges of 1:100,000)
Rationale: The American Heart Association and ADA recommend limiting
epinephrine to 0.04 mg (approximately 2 cartridges of 1:100,000) for patients with
significant cardiovascular disease, including uncontrolled hypertension. Standard
healthy patient limit is 0.2 mg. Options C and D exceed safe cardiovascular
thresholds.
Question 7: Which clinical sign is the EARLIEST indicator of local anesthetic systemic
toxicity (LAST)?
A. Tonic-clonic seizures
B. Cardiovascular collapse
C. Perioral numbness and tinnitus
D. Respiratory arrest
CORRECT ANSWER: C. Perioral numbness and tinnitus
Page 3 of 195
, Rationale: Central nervous system excitation occurs first due to lower seizure
threshold. Early signs include metallic taste, tinnitus, perioral numbness, dizziness,
and restlessness. Seizures (A) and respiratory arrest (D) are progressive CNS
depressant phases. Cardiovascular collapse (B) occurs later due to myocardial
depression.
Question 8: A patient experiences syncope during local anesthetic administration.
Which mechanism is PRIMARILY responsible?
A. Anaphylactic reaction to preservatives
B. Epinephrine-induced tachycardia
C. Vasovagal response causing cerebral hypoperfusion
D. Intravascular injection of anesthetic
CORRECT ANSWER: C. Vasovagal response causing cerebral hypoperfusion
Rationale: Syncope (fainting) is the most common dental emergency, typically
triggered by anxiety, pain, or prolonged standing, leading to vagal-mediated
vasodilation and bradycardia. This reduces cerebral perfusion. Anaphylaxis (A)
presents with bronchospasm and urticaria. Epinephrine (B) causes tachycardia, not
syncope. Intravascular injection (D) causes toxicity, not simple syncope.
Question 9: Which local anesthetic is associated with methemoglobinemia,
particularly in pediatric patients?
A. Lidocaine
B. Articaine
C. Prilocaine
D. Mepivacaine
CORRECT ANSWER: C. Prilocaine
Rationale: Prilocaine metabolizes to o-toluidine, which oxidizes hemoglobin to
methemoglobin, reducing oxygen-carrying capacity. Risk increases with doses >600
mg and in infants <6 months or patients with G6PD deficiency. Methylene blue is
the antidote. Lidocaine (A), articaine (B), and mepivacaine (D) do not carry this risk.
Question 10: A patient reports a "swollen lip" lasting 5 hours after mandibular
block. Which complication is MOST likely?
A. Allergic reaction
Page 4 of 195
